Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jonathan G. Leung, PharmD"'
Autor:
Matthew Nuebel, PharmD, Jonathan G. Leung, PharmD, Christopher Hughes, PhD, Ian McGrane, PharmD
Publikováno v:
Mental Health Clinician, Vol 14, Iss 3, Pp 204-211 (2024)
Introduction Clozapine is the only antipsychotic approved for treatment-resistant schizophrenia, but without appropriate monitoring, it can be associated with potentially fatal outcomes. An International Adult Clozapine Titration Guideline categorize
Externí odkaz:
https://doaj.org/article/bbc5395704714d0ea55243e6ca4f78c9
Publikováno v:
Mental Health Clinician, Vol 13, Iss 6, Pp 276-288 (2023)
The concept of ethnopsychopharmacology aims to predict or explain the pharmacologic response to psychiatric medications based on the influence of biologic and nonbiologic factors. Interactions involving these factors are complex and influence patient
Externí odkaz:
https://doaj.org/article/df52d9314d224714a41f06c32402d748
Autor:
Dylan L. Kosaski, PharmD, Kristin C. Cole, Jessica A. Wright, Razan M. El Melik, PharmD, Simon Kung, MD, Wayne T. Nicholson, MD, PharmD, Jonathan G. Leung, PharmD
Publikováno v:
Mental Health Clinician, Vol 13, Iss 6, Pp 303-310 (2023)
Introduction: Although there are studies assessing reasons for antidepressant discontinuation, little is known about the impact of sex differences or cytochrome P450 phenotypes. Our objective is to assess discontinuation rates between males and femal
Externí odkaz:
https://doaj.org/article/f5adae5ad7144ff49dbe80593e6fe2d3
Autor:
Joseph C. Osborne, II, PharmD, Susan E. Horsman, PharmD, BCPS, Kristin C. Mara, MS, Thomas C. Kingsley, MD, MPH, Robert W. Kirchoff, MD, Jonathan G. Leung, PharmD, BCPS, BCPP
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 6, Iss 1, Pp 1-9 (2022)
Objective: To investigate medication factors and patient characteristics associated with readmissions following alcohol-related hospitalizations. Patients and Methods: Adult patients admitted from September 1, 2016, through August 31, 2019, who had a
Externí odkaz:
https://doaj.org/article/1145aaeddf1848cc9377731d5139c807
Autor:
Ruth E. Bates, MD, Jonathan G. Leung, PharmD, RPh, Robert J. Morgan, III, MD, Karen M. Fischer, MPH, Kemuel L. Philbrick, MD, Simon Kung, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 4, Iss 5, Pp 542-549 (2020)
Objective: To evaluate the efficacy and safety of a fixed-dose gabapentin taper protocol for alcohol withdrawal in hospitalized patients. Patients and Methods: We retrospectively identified patients admitted to the hospital from January 1, 2016, to A
Externí odkaz:
https://doaj.org/article/76c61b0ffb484cf584fbe142eeafd2cd